Abstract

Simple SummaryThe relationship between diabetes, dementia and neuronal injury defines type 3 diabetes (T3D). Similar retinal vessel changes were observed in Alzheimer’s and chronic stressed individuals. The aim was to assess associations of chronic stress with T3D and retina pathology. An established validated chronic stress and stroke risk score (hereafter Stress) stratified participants into Stressed (high stress) and non-Stressed (low stress) groups. Early dementia signs (insulin sensitivity, cognitive dysfunction, neuronal injury) were evident in Stressed compared to non-Stressed individuals. Stress was associated with poor retinal oxygen perfusion, potentiating glaucoma risk. Stress was further related to four dementia risk markers (cognitive dysfunction; telomere shortening, neuronal injury and waist circumference), which comprised a novel Stress syndrome prototype. This prototype showed high risk for T3D as well as retinal vein widening and perfusion deficits, indicating stroke risk. Findings should increase awareness on the detrimental role of chronic stress in the human brain.Type 3 diabetes (T3D) accurately reflects that dementia, e.g., Alzheimer’s disease, represents insulin resistance and neurodegeneration in the brain. Similar retinal microvascular changes were observed in Alzheimer’s and chronic stressed individuals. Hence, we aimed to show that chronic stress relates to T3D dementia signs and retinopathy, ultimately comprising a Stress syndrome prototype reflecting risk for T3D and stroke. A chronic stress and stroke risk phenotype (Stressed) score, independent of age, race or gender, was applied to stratify participants (N = 264; aged 44 ± 9 years) into high stress risk (Stressed, N = 159) and low stress risk (non-Stressed, N = 105) groups. We determined insulin resistance using the homeostatic model assessment (HOMA-IR), which is interchangeable with T3D, and dementia risk markers (cognitive executive functioning (cognitiveexe-func); telomere length; waist circumference (WC), neuronal glia injury; neuron-specific enolase/NSE, S100B). Retinopathy was determined in the mydriatic eye. The Stressed group had greater incidence of HOMA-IR in the upper quartile (≥5), larger WC, poorer cognitiveexe-func control, shorter telomeres, consistently raised neuronal glia injury, fewer retinal arteries, narrower arteries, wider veins and a larger optic cup/disc ratio (C/D) compared to the non-Stressed group. Furthermore, of the stroke risk markers, arterial narrowing was related to glaucoma risk with a greater C/D, whilst retinal vein widening was related to HOMA-IR, poor cognitiveexe-func control and neuronal glia injury (Adjusted R2 0.30; p ≤ 0.05). These associations were not evident in the non-Stressed group. Logistic regression associations between the Stressed phenotype and four dementia risk markers (cognitiveexe-func, telomere length, NSE and WC) comprised a Stress syndrome prototype (area under the curve 0.80; sensitivity/specificity 85%/58%; p ≤ 0.001). The Stress syndrome prototype reflected risk for HOMA-IR (odds ratio (OR) 7.72) and retinal glia ischemia (OR 1.27) and vein widening (OR 1.03). The Stressed phenotype was associated with neuronal glia injury and retinal ischemia, potentiating glaucoma risk. The detrimental effect of chronic stress exemplified a Stress syndrome prototype reflecting risk for type 3 diabetes, neurodegeneration and ischemic stroke.

Highlights

  • One of the major modifiable risk factors for stroke is diabetes, which may cause pathologic changes in cerebral blood vessels [1,2]

  • The Stressed group showed higher prevalence of smoking and greater alcohol consumption as well as more dementia and retinal vascular dysregulation risk signs compared to the non-Stressed group (p < 0.05)

  • The findings of our analysis showed that the Stressed group had (1) increased dium; 4.25main

Read more

Summary

Introduction

One of the major modifiable risk factors for stroke is diabetes, which may cause pathologic changes in cerebral blood vessels [1,2]. Impairments in cerebral glucose utilization and insulin resistance [3] further accompany the initial stages of cognitive impairment [4] and neurodegenerative diseases [5]. Peripheral insulin resistance (IR) is accompanied by central nervous system IR and might increase the risk of dementia neuropathology [8]. IR at cellular level in midlife was shown to be an independent risk factor for brain amyloid accumulation in individuals without dementia [8]. Using the term type 3 diabetes (T3D) rather accurately reflects the fact that dementia, e.g., Alzheimer’s disease (AD), represents insulin resistance in the brain, with molecular and biochemical features that overlap with both type 1 diabetes mellitus [9] and type 2 diabetes [9,10,11]

Objectives
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call